Smith & Nephew (STU:NPW1) Tax Provision : €-25 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Smith & Nephew Tax Provision?

Smith & Nephew's tax provision for the six months ended in Jun. 2024 was €-36 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2024 was €-25 Mil.

Smith & Nephew Tax Provision Historical Data

The historical data trend for Smith & Nephew's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Tax Provision Chart

Smith & Nephew Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-128.70

166.04

-54.87

-11.33

-24.76

Smith & Nephew Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Tax Provision	Get a 7-Day Free Trial															-25.54	14.16	-36.00	11.00	-36.23

Smith & Nephew Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-25 Mil.

Smith & Nephew Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (STU:NPW1) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNN:USA SN1:Mexico SNl:UK SN.:UK NPWA:Germany NPW1:Germany

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Headlines

No Headlines